Robert Cox
Stock Analyst at Goldman Sachs
(2.67)
# 2,017
Out of 4,876 analysts
24
Total ratings
72.73%
Success rate
11%
Average return
Main Sectors:
Stocks Rated by Robert Cox
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AHL Aspen Insurance Holdings | Initiates: Neutral | $38 | $30.41 | +24.96% | 1 | Jun 2, 2025 | |
| WRB W. R. Berkley | Downgrades: Neutral | $74 → $76 | $72.34 | +5.06% | 2 | May 22, 2025 | |
| AON Aon plc | Upgrades: Buy | $408 | $353.55 | +15.40% | 3 | May 13, 2025 | |
| BRO Brown & Brown | Downgrades: Neutral | $126 → $119 | $109.27 | +8.90% | 3 | May 13, 2025 | |
| RYAN Ryan Specialty Holdings | Upgrades: Buy | $74 → $81 | $67.23 | +20.48% | 5 | May 13, 2025 | |
| FIHL Fidelis Insurance Holdings | Downgrades: Sell | $21 → $16 | $16.31 | -1.90% | 2 | Jan 8, 2025 | |
| AJG Arthur J. Gallagher & Co. | Downgrades: Neutral | $313 | $318.39 | -1.69% | 2 | Nov 25, 2024 | |
| MMC Marsh & McLennan Companies | Maintains: Sell | $215 → $185 | $216.02 | -14.36% | 3 | Jan 9, 2024 | |
| WTW Willis Towers Watson | Upgrades: Buy | $290 | $301.90 | -3.94% | 3 | Feb 27, 2023 |
Aspen Insurance Holdings
Jun 2, 2025
Initiates: Neutral
Price Target: $38
Current: $30.41
Upside: +24.96%
W. R. Berkley
May 22, 2025
Downgrades: Neutral
Price Target: $74 → $76
Current: $72.34
Upside: +5.06%
Aon plc
May 13, 2025
Upgrades: Buy
Price Target: $408
Current: $353.55
Upside: +15.40%
Brown & Brown
May 13, 2025
Downgrades: Neutral
Price Target: $126 → $119
Current: $109.27
Upside: +8.90%
Ryan Specialty Holdings
May 13, 2025
Upgrades: Buy
Price Target: $74 → $81
Current: $67.23
Upside: +20.48%
Fidelis Insurance Holdings
Jan 8, 2025
Downgrades: Sell
Price Target: $21 → $16
Current: $16.31
Upside: -1.90%
Arthur J. Gallagher & Co.
Nov 25, 2024
Downgrades: Neutral
Price Target: $313
Current: $318.39
Upside: -1.69%
Marsh & McLennan Companies
Jan 9, 2024
Maintains: Sell
Price Target: $215 → $185
Current: $216.02
Upside: -14.36%
Willis Towers Watson
Feb 27, 2023
Upgrades: Buy
Price Target: $290
Current: $301.90
Upside: -3.94%